PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW
PSYENCE BIOMEDICAL LTD.
Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 20-F on Jun 22, 2026
$4.12−0.10 (-2.37%)
Close on Oct 19, 2026
- Market cap
- $6.10M
- P/E (TTM)
- 0.8
- Dividend yield
- –
Dividends
Psyence Biomedical has not reported a dividend
No dividend per share appears in Psyence Biomedical's annual filings since fiscal 2022.